Today's Rundown Featured Story | | | Monday, June 1, 2020 Eli Lilly has begun dosing COVID-19 patients in a phase 1 trial of its AbCellera-partnered antibody. The initiation of the trial, which happened ahead of schedule, marks the start of a new phase of the response to SARS-CoV-2 in which study subjects will receive drugs designed specifically for the virus. |
|
|---|
|
Top Stories Monday, June 1, 2020 Regeneron is doubling down on its collaboration with gene-editing biotech Intellia as they expand into work for hemophilia A and B. Monday, June 1, 2020 AbbVie has signed a new pact to focus on SHP2 inhibitors, which target a key node in cancer and immune cells, from early-stage biotech Jacobio Pharmaceuticals. Monday, May 25, 2020 Jazz Pharmaceuticals is applying its proprietary technology to recognize the potential of combination therapy for treating cancer patients and redefining what is possible in the treatment landscape. Monday, June 1, 2020 Two doses of Antibe Therapeutics’ chronic pain drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to nonsteroidal anti-inflammatory drugs, which are commonly used to treat osteoarthritis as well as other ailments that cause chronic pain. Monday, June 1, 2020 Legend Biotech is living up to its name as it sets terms for a massive $350 million IPO, while early-stage cancer biotech Repare Therapeutics and blood-disease-focused Forma Therapeutics also look to go public. Sunday, May 31, 2020 The FDA is looking to add more tests to its list of authorized, home-based coronavirus diagnostics following its recent green lights for lab testing giant Quest Diagnostics and direct-to-consumer company LetsGetChecked. Friday, May 29, 2020 It’s reasonable to assume PD-1 inhibitors like Bristol Myers Squibb's Opdivo, which unleash the body’s own immune system to target and destroy cancer, work best in “hot” tumors that are flooded with immune cells. But a new study by scientists at the Dana-Farber Cancer Institute found that is not the case in kidney cancer. While the list of the best-paid biopharma CEOs of 2019 includes some of the world's largest drugmakers, you'll also find smaller companies among them. And the CEO at No. 1 could be a surprise. |  | LabConnect is now offering global analytical and operational services to meet your COVID-19 testing requirements. We offer viral load testing by RT-qPCR and multiple COVID-19 screening assays. Connect with LabConnect today. We are here to help. |
Enrollment Showcase | | | Sponsored by: University of Florida College of Pharmacy Position yourself as a precision medicine leader with the online graduate program in precision medicine. Learn the latest in genomic technologies and precision medicine therapies from experts in research and implementation. Join the future of health care with the flexibility and convenience of an online program. |
|
|---|
|
Resources Sponsored by: Blue Matter, strategic consultants in the life sciences White paper describing 7 keys to success for any biopharma company that is entering (or thinking about entering) Europe. Sponsored by: Clinical Ink This white paper covers a Phase III case study; BYOD advantages and misconceptions; and regulatory, copyright, and equivalency considerations. Sponsored by: Clinical Ink Learn how GI specific data capture solutions can support virtual and hybrid trials during COVID-19. Sponsored by: Copyright Clearance Center Dive into the history of biomedical classification and how these systems have evolved to address new technology and use cases. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Frontage Laboratories, Inc. Listen to our brand-new Frontage Laboratories podcast where you’ll take home tips for developing residual host cell proteins ELISA assay for biopharmaceutical products using commercial kits. Wednesday, May 20, 2020 | Time: 10am-3.30pm (BST) Join us for a day of discovery as global experts in Cardiology, Pharmacology and Diabetes discuss state of the art methods in early phase clinical research. Sponsored by: Oracle Health Sciences Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual." Sponsored by: Outer Edge Technology Covid-19 has forever changed the paradigm of “go to the office” business operations. Learn how an effective Cloud Strategy can position your company for success in these unprecedented times. Sponsored by: Cenduit, LLC Download this case study to read about how Cenduit navigated these challenges, and successfully supports the trial sponsor to execute the umbrella trial with agility. Sponsored by: Acorn AI by Medidata, a Dassault Systèmes company Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI. Sponsored by: Clarify Health Pharma launch teams spend significant resources on data and analytics with limited ROI. Read this case study to learn how a Life Sciences company identified two times more patients best suited for therapy, using Clarify’s deep and longitudinal patient and HCP insights. | 
